DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Sweden
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
BONEX logo

Bonesupport Holding AB (publ) Stock Price

OM:BONEX Community·SEK 14.8b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 57 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

BONEX Share Price Performance

SEK 226.40
-80.80 (-26.30%)
​
SEK 373.83
Fair Value
SEK 226.40
-80.80 (-26.30%)
39.4% undervalued intrinsic discount
SEK 373.83
Fair Value
Price SEK 226.40
AnalystConsensusTarget SEK 373.83
AnalystLowTarget SEK 275.00
AnalystHighTarget SEK 428.00
Wed, 17 Jun 26
Fair ValueSEK 373.83
Share Pricen/a

BONEX Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value SEK 373.83 39.4% undervalued intrinsic discount

Positive Clinical Results And US Launch Will Drive Future Success

0users have liked this narrative
0users have commented on this narrative
29users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value SEK 275 17.7% undervalued intrinsic discount

Slow Trauma Center Adoption And Regulatory Hurdles Will Eventually Support A Healthier Business Mix

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value SEK 428 47.1% undervalued intrinsic discount

US Trauma Expansion And New Surgical Uses Will Transform This Bone Regeneration Specialist

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
BONEX logo
Bonesupport Holding
39.4% undervalued intrinsic discount

Positive Clinical Results And US Launch Will Drive Future Success

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 17 Jun
Read Narrative
BONEX logo
Bonesupport Holding
17.7% undervalued intrinsic discount

Slow Trauma Center Adoption And Regulatory Hurdles Will Eventually Support A Healthier Business Mix

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 20 Jul
Read Narrative
BONEX logo
Bonesupport Holding
47.1% undervalued intrinsic discount

US Trauma Expansion And New Surgical Uses Will Transform This Bone Regeneration Specialist

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Published 25 Feb
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
BONEX logo

BONEX: Share Buybacks Will Support Bullish Case Despite Lowered Growth Assumptions

Fair Value: SEK 275 17.7% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
BONEX logo

BONEX: Share Buybacks And Margin Strength Will Drive Future Upside

Fair Value: SEK 373.83 39.4% undervalued intrinsic discount
29 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
BONEX logo

US Trauma Expansion And New Surgical Uses Will Transform This Bone Regeneration Specialist

Fair Value: SEK 428 47.1% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Exceptional growth potential with flawless balance sheet.

0 Risks
3 Rewards
View Full Analysis

Bonesupport Holding AB (publ) Key Details

SEK 1.3b

Revenue

SEK 102.3m

Cost of Revenue

SEK 1.2b

Gross Profit

SEK 970.2m

Other Expenses

SEK 213.9m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 22, 2026
3.27
92.05%
16.63%
0%
View Full Analysis

About BONEX

Founded
1999
Employees
171
CEO
Torbjorn Skold
WebsiteView website
www.bonesupport.com

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Recent BONEX News & Updates

User avatar
Narrative Update • Jul 20

BONEX: Share Buybacks Will Support Bullish Case Despite Lowered Growth Assumptions

Analysts have reduced their price target for Bonesupport Holding to SEK275 from SEK310, reflecting updated assumptions around a slightly higher discount rate, more moderate revenue growth, a marginally stronger profit margin, and a lower future P/E multiple. What's in the News for Bonesupport Holding Bonesupport Holding AB (publ) plans to commence a share repurchase program on June 9, 2026, following a mandate from the Annual General Meeting on May 12, 2026.
Analysis Article • Jul 19

Results: Bonesupport Holding AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

It's been a mediocre week for Bonesupport Holding AB (publ) ( STO:BONEX ) shareholders, with the stock dropping 16% to...

Recent updates

No updates

Bonesupport Holding AB (publ) Competitors

SOBI logo

Swedish Orphan Biovitrum

Symbol: OM:SOBI
Market cap: SEK 152.7b
CAMX logo

Camurus

Symbol: OM:CAMX
Market cap: SEK 35.1b
BIOA B logo

BioArctic

Symbol: OM:BIOA B
Market cap: SEK 29.0b
ALIF B logo

AddLife

Symbol: OM:ALIF B
Market cap: SEK 18.7b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide